The American Cancer Society prefers to avoid public confrontation with corporate donors, even those who make money by selling tobacco products.
When CVS made the decision to forego tobacco sales, the estimated $2 billion in annual revenues it gave up amounts to more than twice the amount of money ACS collects in a year (The Cancer Letter, Feb. 7). However, ACS positions itself as the vanguard of tobacco control, and critics say that close association with a retailer that profits from tobacco undermines the society's own goals and harms its brand.
Last week, a blistering opinion piece on The New York Times editorial page focused on the coziness of the relationship between the American Cancer Society and Walgreens. The piece initially triggered criticism by ACS officials, but then—with no fanfare whatsoever—the society’s CEO called on the drug store chain, as well as others, to stop selling tobacco […]
Almost one decade ago, Laurie Fenton-Ambrose, president and CEO of the Lung Cancer Alliance, described the National Lung Screening Trial as “failed” and “outdated.”
CCOP Letter to VarmusThe letter to Varmus was signed by 56 of the 64 CCOP PIs.
The Gap OpensMany doctors who participate in CCOPs commit money from their practices to this endeavor. Institutions, too, end up having to throw in subsidies.
The American Association for Cancer Research presented its 2014 awards at its annual meeting, held April 5-9 in San Diego.
President Barack Obama signed a bill authorizing $126 million for pediatric medical research over the next 10 years, following a rare showing of bipartisanship on Capitol Hill.
For a good time, go to the Medicare database and key in the name of your physician friend, foe, or whatever, and presto!—you will see how much that person had billed Medicare in 2012.
Following an explosion of criticism, NCI said funding for community oncology clinics would not be interrupted.
